Gallant, Joel

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 6,873

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 3,098

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 2,119

Antiretroviral therapy for the prevention of HIV-1 transmission.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 1,700

Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients<SUBTITLE>A 3-Year Randomized Trial</SUBTITLE>

Gallant, J. E. (2004) · JAMA

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 1,341